Copyright
©The Author(s) 2024.
World J Virol. Mar 25, 2024; 13(1): 89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104
Patient | 0 months | 6th months | 12th months | |||
HBV DNA | Liver enzymes | HBV DNA | Liver enzymes | HBV DNA | Liver enzymes | |
1 | TND | Normal | TND | Normal | TND | Normal |
2 | TND | Normal | TND | Normal | TND | Normal |
3 | TND | Normal | TND | Normal | TND | Normal |
4 | TND | Normal | TND | Normal | TND | Normal |
5 | TND | Normal | TND | Normal | TND | Normal |
6 | TND | Normal | TND | Normal | TND | Normal |
7 | TND | Normal | TND | Normal | TND | Normal |
8 | HIGH | Elevated > 2X UNL | TND | Normal | TND | Normal |
9 | HIGH | Elevated > 2X UNL | TND | Normal | TND | Normal |
- Citation: Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104
- URL: https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i1.89104